Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
PRTA Prothena
- 15.140
- -0.600-3.81%
Close Dec 27 16:00 ET
- 15.140
- 0.0000.00%
Post 16:20 ET
814.66MMarket Cap-6.15P/E (TTM)
15.800High14.800Low475.20KVolume15.590Open15.740Pre Close7.19MTurnover1.26%Turnover RatioLossP/E (Static)53.81MShares41.54552wk High1.52P/B570.89MFloat Cap11.70052wk Low--Dividend TTM37.71MShs Float79.749Historical High--Div YieldTTM6.35%Amplitude5.640Historical Low15.120Avg Price1Lot Size
About Prothena Company
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Company Profile
SymbolPRTA
Company NameProthena
Listing DateDec 18, 2012
Founded2012
CEODr. Gene G. Kinney, PhD
MarketNASDAQ
Employees173
Fiscal Year Ends12-31
Address77 Sir John Rogersons Quay,Grand Canal Docklands,Block C
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-236-2500
Websitehttp://www.prothena.com
Company Executives
- Name
- Position
- Salary
- Dr. Gene G. Kinney, PhD
- Director, President and Chief Executive Officer
- 7.04M
- Chad J. Swanson
- Chief Development Officer
- --
- Brandon S. Smith
- Chief Operating Officer
- 2.63M
- Wagner M. Zago
- Chief Scientific Officer
- --
- Dr. Radhika Tripuraneni, M.D.,M.P.H.
- Chief Development Officer
- --
- Karin L. Walker
- Chief Accounting Officer
- --
- Tran B. Nguyen
- Chief Strategy Officer and Chief Financial Officer
- 2.70M
- Carol D. Karp
- Chief Regulatory Officer
- 2.57M
- Michael J. Malecek
- Chief Legal Officer and Company Secretary
- --
- Dr. Lars G. Ekman, M.D.,PhD
- Chairman Emeritus and Director
- 923.48K
- Daniel G. Welch
- Chairman of the Board
- --
- Dr. William H. Dunn, Jr
- Director
- 1.70M
- Oleg Nodelman
- Independent Director
- --
- Paula K. Cobb
- Independent Director
- 908.48K
- Shane M. Cooke
- Independent Director
- 917.26K
- Richard T. Collier
- Independent Director
- 912.48K
- Helen S. Kim
- Independent Director
- 896.63K
- Dr. Dennis J. Selkoe, M.D.
- Independent Director
- 901.73K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.